Sanyin Bio
圣因生物
Sanyin Bio
Biotech/Healthcare
Founded in early 2021, Shengyin Biotech is a biopharmaceutical company focused on developing novel small nucleic acid drugs based on RNA interference (RNAi) technology, with R&D centers in China and the United States. Its founding team comprises seasoned experts in nucleic acid drugs, with…
Latest round: Series B (2025)
Source: ChinaBulls — chinabulls.com
Last updated 2025-12-01
Funding history
Request access to view this section.
Investors
Request access to view this section.
HQ & website
Request access to view this section.
Tags
Request access to view this section.